Errik Anderson

Errik Anderson is the founder, CEO, and Chairman of Alloy Therapeutics. Prior to this, they were with Major League Rugby, WelbeHealth, New England Free Jacks, and Compass Therapeutics LLC. Errik has also been a part of Ulysses Diversified Holdings and Alector.Anderson has a long history of success in the biotech industry. Errik has been a part of several successful startups including Adimab, LLC. Arsanis, and Alloy Therapeutics, Inc.

Errik Anderson has a MBA from The Tuck School of Business at Dartmouth, an M.S. in Biomolecular Engineering from Thayer School of Engineering at Dartmouth (which they did not finish), and an A.B. in Economics from Dartmouth College.

Some individuals on their team include Heather Schwoebel - Chief Business Officer & COO, Piotr Bobrowicz - Chief Scientific Officer, and Logan Snyder - General Counsel.